Location: Home
  • search
  • go
  • Relate News
  • 4/14/2023CDE Issues the Technical Guidelines for Clinical Research of New Compo...
  • 4/14/2023Drug R&D and Product Registration News Digest April 2023 (2)
  • 4/14/2023Recent Executive Moves
  • 4/13/2023Chinese VMS OTC Market Growth Slows to 5.3% in 2022 amid Covid-related...
  • 4/13/2023Pfizer Collaborates with Sinopharm to Expand in China
  • 4/13/2023China to Establish A Vaccine Development Center with Brazil
  • 4/12/2023Specialised Therapeutics Partners with CTTQ-Akeso to Commercialise Ne...
  • 4/12/2023China Issues Action Plan to Combat Endemic Diseases
  • 4/12/2023CDE Issues the Technical Guidelines for Clinical Trials of Respiratory...
  • 4/12/2023CDE Issues the Technical Guidelines of Quantitative Methodologies for ...
  • 4/12/2023CDE Issues the List of External Clinical Evaluation Experts of Pediatr...
  • 4/12/2023Bain: China Drags Regional Healthcare PE
  • 4/12/2023Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades
  • 4/12/2023Outlook of China's Health Systems (Informa)
  • 4/12/2023Trailing AstraZeneca and Merck, Junshi Reports Phase 3 Ovarian Cancer ...
  • 4/11/2023 Seizing On Asia's Opportune Market for Novel Vaccines (PharmExec/Simo...
  • 4/11/2023A Brief Review of China Pharmaceutical Anti-Monopoly in the Year of 20...
  • 4/11/2023NMPA Solicits Public Comments on the Drug Regulatory Informatization S...
  • 4/10/2023FT: Astellas to Stay Put in China Despite Growing Geopolitical Tension
  • 4/8/2023CDE Issues the Technical Guidelines for Clinical Research of Antitumor...
  • 4/8/2023CDE Issues on the Technical Guidelines for Drug Research Based on Anim...
  • 4/8/2023South Korean Biotech Companies Seek to Diversify from China as US Tens...
  • 4/8/2023Recent Executive Moves
  • 4/8/2023Drug R&D and Registration News Digest April 2023 (1)
  • 4/8/2023EU-China Relations – Trade, Investment, and Recent Developments (Chin...
  • 4/8/2023Investing in China's Greater Bay Area: Tapping into Long-Term Opportun...
  • 4/6/2023A Recently Terminated In-Licensing Deal Highlights Why Regulatory Diff...
  • 4/5/2023China's Out-Licensing Boom Continued in February with Big Oncology Dru...
  • 4/5/2023WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...
  • 4/5/2023Pharmaron Plans UK Gene Therapy Expansion
  • Page:50/719 Total number of articles:21546: [First][<<] [48] [49] [50] [51] [52] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group